Announcement Coming, page-98

Oh dear, these threads have become agonisingly dull. Here's how I see it:

ADO - a speculative investment with potentially stellar upside potential, yet to prove itself and potentially taking a little longer than anticipated (as is often the case in biotech). Actively engaging heavyweights across the life sciences with no rejections and chalking up ever more impressive data supporting the performance of it's technology. Huge potential outside of lifesciences. Bolstering IP all the time, tight capital management, great management with experience and proven track records both on a corporate and sector level.

Near term news regarding Alere, the world leader in POC, who thus far have massively improved their test performance whilst reducing their costs. POC1 on the cusp of producing the first POC cardiac test with lab analyser performance. Many other relationships cooking in the background. Clinch either of these deals and ADO becomes profitable, is de-risked and can look to grow rapidly into other areas. Otherwise in house products might bridge the gap to profitability.

There's potentially more waiting time before these things happen, and the macro environment is looking to turn ugly any minute also the technicals aren't solid. One might find a better entry by waiting but company making news could literally arrive tomorrow.

To imply that ADO are just a paper printing machine is nonsense, to suggest that they have nothing of tangible value is nonsense, to suggest they'll be at a dollar in a couple of months is nonsense.

Please don't buy or sell based upon what I or lexcorp say, maybe you should read the company releases and Twinvests blog. If you don't like risk perhaps a term deposit or something similar is better for you instead?